vivo optical imaging analyses Search Results


vivo imaging system  (MILabs)
95
MILabs vivo imaging system
Vivo Imaging System, supplied by MILabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/Optical+Imaging/pmc09318050-105-24-33
Average 95 stars, based on 1 article reviews
vivo imaging system - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
ivis spectrum oi system  (Revvity)
91
Revvity ivis spectrum oi system
Ivis Spectrum Oi System, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/IVIS+SpectrumBL+High-Throughput+In+Vivo+Optical+Imaging+System/pmc07738859-36-8-12
Average 91 stars, based on 1 article reviews
ivis spectrum oi system - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
wavelength-resolved maestro in vivo optical imaging system  (CRI Medical Devices)
90
CRI Medical Devices wavelength-resolved maestro in vivo optical imaging system
Wavelength Resolved Maestro In Vivo Optical Imaging System, supplied by CRI Medical Devices, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/wavelength+resolved+maestro+in+vivo+optical+imaging+system/pmc04149327-198-11-17
Average 90 stars, based on 1 article reviews
wavelength-resolved maestro in vivo optical imaging system - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
optical in vivo imaging system maestrotm2.2  (CRI Medical Devices)
90
CRI Medical Devices optical in vivo imaging system maestrotm2.2
Optical In Vivo Imaging System Maestrotm2.2, supplied by CRI Medical Devices, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/optical+in+vivo+imaging+system+maestrotm2+2/pmc05102448-136-11-19
Average 90 stars, based on 1 article reviews
optical in vivo imaging system maestrotm2.2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
in vivo optical imaging  (Promega)
90
Promega in vivo optical imaging
In Vivo Optical Imaging, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/in+vivo+optical+imaging/10__1158_slash_1535___7163__mct___19___0491-68-12-27
Average 90 stars, based on 1 article reviews
in vivo optical imaging - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
transmission light microscope with progres capture system  (JENOPTIK Inc)
90
JENOPTIK Inc transmission light microscope with progres capture system
Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the <t>ProgRes</t> Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).
Transmission Light Microscope With Progres Capture System, supplied by JENOPTIK Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/progress+capture+28+8+jenoptik+optical+system+image+analyser+software/pmc07349116-106-19-22
Average 90 stars, based on 1 article reviews
transmission light microscope with progres capture system - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vivo optical imaging system  (Guangzhou Biolight Biotechnology Co Ltd)
86
Guangzhou Biolight Biotechnology Co Ltd vivo optical imaging system
Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the <t>ProgRes</t> Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).
Vivo Optical Imaging System, supplied by Guangzhou Biolight Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/imaging+optical+system+vivo/pm42035111-137-9-15
Average 86 stars, based on 1 article reviews
vivo optical imaging system - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
hsi analyser spectral image software  (ISUZU Optics)
90
ISUZU Optics hsi analyser spectral image software
Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the <t>ProgRes</t> Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).
Hsi Analyser Spectral Image Software, supplied by ISUZU Optics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/hsi+analyser+spectral+image+software/10__1016_slash_j__infrared__2020__103220-95-9-14
Average 90 stars, based on 1 article reviews
hsi analyser spectral image software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
spectral image analyser  (ISUZU Optics)
90
ISUZU Optics spectral image analyser
Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the <t>ProgRes</t> Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).
Spectral Image Analyser, supplied by ISUZU Optics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/spectral+image+analyser/pm25170577-90-5-8
Average 90 stars, based on 1 article reviews
spectral image analyser - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ivis optical imaging platform  (Revvity)
96
Revvity ivis optical imaging platform
Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the <t>ProgRes</t> Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).
Ivis Optical Imaging Platform, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/IVIS+optical+imaging+platform/custom%40cls158738%4039981785
Average 96 stars, based on 1 article reviews
ivis optical imaging platform - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
whole-body optical imaging system cri's new maestrotm ex in-vivo imaging system  (CRI Medical Devices)
90
CRI Medical Devices whole-body optical imaging system cri's new maestrotm ex in-vivo imaging system
Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the <t>ProgRes</t> Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).
Whole Body Optical Imaging System Cri's New Maestrotm Ex In Vivo Imaging System, supplied by CRI Medical Devices, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/whole+body+optical+imaging+system+cri+s+new+maestrotm+ex+in+vivo+imaging+system/pm22794122-114-1-12
Average 90 stars, based on 1 article reviews
whole-body optical imaging system cri's new maestrotm ex in-vivo imaging system - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
in-vivo xtreme optical and x-ray small-animal imaging system  (Carestream Molecular Imaging)
90
Carestream Molecular Imaging in-vivo xtreme optical and x-ray small-animal imaging system
Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the <t>ProgRes</t> Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).
In Vivo Xtreme Optical And X Ray Small Animal Imaging System, supplied by Carestream Molecular Imaging, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vivo+optical+imaging+analyses/in+vivo+xtreme+optical+and+x+ray+small+animal+imaging+system/10__1089_slash_gen__32__1__12-27-8-2
Average 90 stars, based on 1 article reviews
in-vivo xtreme optical and x-ray small-animal imaging system - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the ProgRes Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).

Journal: Cells

Article Title: Proteins and Molecular Pathways Relevant for the Malignant Properties of Tumor-Initiating Pancreatic Cancer Cells

doi: 10.3390/cells9061397

Figure Lengend Snippet: Inhibition of S100A8, S100A9, and LGALS3BP expression impairs migration of pancreatic cancer cell line L3.6sl. ( A ) Representative images of the specific knockdown cells (shS100A8, shS100A9, and shLGALS3BP) compared to non-target control shRNA cells (sh ctrl) shown are after 0.0, 6.0, 12.0, and 24.0 h. Black lines enclose areas free of migratory cancer cells. Quantification of migration ability over time ( B ): 0.0 h control shRNA area was set to 0%; all other values were normalized accordingly. Measurements were done with the ProgRes Software. Error bars represent standard deviations of six measurements. Statistical significances were assessed by a two-way ANOVA followed by a Dunnett’s post-hoc test (* for p ≤ 0.05, ** for p ≤ 0.01. and *** for p ≤ 0.001, n = 6).

Article Snippet: Cell movement was assessed after 0.0, 6.0, 12.0, and 24.0 h and documented using a transmission light microscope with ProgRes capture system (Jenoptik GmbH, Jena, Germany).

Techniques: Inhibition, Expressing, Migration, Knockdown, Control, shRNA, Software